SCHEMBL20037487

SCHEMBL20037487

Nc1ccc(N2CC[C@@H](N)[C@H](F)C2)nn1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN11 Q06124 6/20 0.37
HRH4 Q9H3N8 5/20 0.36
CHRNB2 P17787 2/20 0.36
CHRNB4 P30926 2/20 0.36
CHRNA3 P32297 2/20 0.36
CHRNA4 P43681 2/20 0.36
LMNA P02545 1/20 0.35
HTT P42858 1/20 0.35
HTR3E A5X5Y0 1/20 0.35
MEN1 O00255 1/20 0.35
HTR3B O95264 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
ALOX15 P16050 1/20 0.35
TSHR P16473 1/20 0.35
NFKB1 P19838 1/20 0.35
HTR3A P46098 1/20 0.35
KMT2A Q03164 1/20 0.35
HTR3D Q70Z44 1/20 0.35
HTR3C Q8WXA8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20037485 1.00 PTPN11 (0.37) PTPN11HRH4CHRNB2CHRNB4CHRNA3
SCHEMBL18291191 0.85 PTPN11 (0.39) PTPN11CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL20936748 0.84 CHRNB2 (0.39) HRH4CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL18290987 0.84 PTPN11 (0.36) PTPN11HRH4CHRNB2CHRNB4CHRNA3
SCHEMBL20037483 0.84 PIK3CA (0.37) HRH4CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL20249335 0.80 HRH4 (0.44) PTPN11HRH4CHRNB2CHRNB4CHRNA3
SCHEMBL20249333 0.80 HRH4 (0.44) PTPN11HRH4CHRNB2CHRNB4CHRNA3
SCHEMBL20037484 0.80 NMT1 (0.37) HRH4HRH3
SCHEMBL18291518 0.80 MAP4K4 (0.37) HRH4CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL18291073 0.80 HRH4 (0.36) HRH4CHRNB2CHRNB4CHRNA3CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3305785-A1 PYRIDO[3,4-d]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF Teijin Pharma Limited (JP) 2018-04-11 EP disclosed